NEW YORK CITY, New York, United States-- Abbott (NYSE: ABT) announced the world's first patient implants of a dual-chamber leadless pacemaker system as part of its AVEIR DR i2i™ pivotal clinical study; the first implant was performed at Na Homolce Hospital in Prague, Czech Republic, led by site principal investigator...